Trial to Evaluate Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults Aged 50 To 64 Years

Pn-MAPS30plusOngoingActive not recruitingPhase 1Open NCT07428759 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

NCT07428759 · Trial Tracker · ComplyRx